SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Demetre Deliyanakis who wrote (16525)3/3/2003 10:07:43 PM
From: Bill Cotter  Read Replies (1) of 78481
 
Hi Demetre; Isn't MRK a much better value amongst the big pharma?
Cap/Sales Sales/share EPS P/E Shs OS
MRK 2.34 23.54 3.40 16.8 2.2 bil
PFE 5.43 5.23 1.80 19.5 6.2 bil
LLY 5.82 10.09 2.54 23.0 1.1 bil
WYE 3.23 11.23 2.44 10.7 1.3 bil
GSK 3.39 10.60 1.98 17.7 3.0 bil

I realize that what's in the pipeline can be a big factor with respect to stock price.

Bill
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News